FDA Approves 'Artificial Pancreas' to Manage Diabetes
From: ECN - 09/29/2016
By: Matthew Perrone

Federal regulators have approved a first-of-a-kind "artificial pancreas", a
device that can help some diabetes patients manage their disease by
constantly monitoring their blood sugar and delivering insulin as needed.

The device from Medtronic was approved Wednesday for patients with Type 1
diabetes, the kind usually diagnosed during childhood. About 5 percent of the
nation's 29 million Americans with diabetes have this type.

Doctors said they have long awaited a device that could help patients around
the clock.

The new MiniMed 670G consists of a drug pump, a sensor that measures blood
sugar and a tube that delivers the insulin. The sensor measures sugar levels
every 5 minutes, infusing or withholding insulin as needed. Patients still
have to manually increase insulin before meals.

Medtronic said the device will cost between $6,000 and $9,000, similar to its
other insulin pumps. 

Read the entire article at:
https://www.ecnmag.com/news/2016/09/fda-approves-artificial-pancreas-manage-diabetes
https://www.mdtmag.com/news/2016/09/fda-approves-artificial-pancreas-manage-diabetes-0

Links:
Medtronic MiniMed 670G
http://www.medtronicdiabetes.com/blog/fda-approves-minimed-670g-system-worlds-first-hybrid-closed-loop-system

Closing the Loop on the Artificial Pancreas
http://spectrum.ieee.org/the-human-os/biomedical/devices/closing-the-loop-on-the-artificial-pancreas

Related:
Launch of New Insulin Pump Design
https://www.mdtmag.com/news/2016/08/launch-new-insulin-pump-design

Wearable Graphene-Based Biomedical Device to Monitor, Combat Diabetes
https://www.ecnmag.com/news/2016/09/fda-approves-artificial-pancreas-manage-diabetes